Literature DB >> 25120745

IL-22 promotes the migration and invasion of gastric cancer cells via IL-22R1/AKT/MMP-9 signaling.

Yinghua Ji1, Xiaoyu Yang2, Jinsong Li3, Zhihong Lu1, Xiaorui Li1, Jian Yu3, Na Li2.   

Abstract

IL-22, one important inflammatory cytokine of the IL-10 family, exerts its functions via IL-22 receptor that is composed of IL-22R1 and IL-10R2 subunits. Although IL-22 expression is reported to be elevated in many cancers, and increased IL-22 expression correlates with tumor progression and poor prognosis, little is known about the role of IL-22 in gastric cancer. In our study, we found that IL-22 stimulation promoted the migration and invasion of SGC-7901 cells. Furthermore, IL-22 increased AKT activation and MMP-9 production in a time- and dose-dependent manner, while knockdown of IL-22R1 attenuated the effect of IL-22 on gastric cancer cells. In addition, blocking of AKT activation suppressed the expression and secretion of MMP-9. Taken together, this present study suggests that IL-22 stimulation enhances the migration and invasion of gastric cancer cells by regulating IL-22R1/AKT/MMP-9 signaling axis.

Entities:  

Keywords:  IL-22; IL-22R1; MMP-9; gastric cancer; invasion; migration

Mesh:

Substances:

Year:  2014        PMID: 25120745      PMCID: PMC4128980     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Identification of the functional interleukin-22 (IL-22) receptor complex: the IL-10R2 chain (IL-10Rbeta ) is a common chain of both the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor, IL-TIF) receptor complexes.

Authors:  S V Kotenko; L S Izotova; O V Mirochnitchenko; E Esterova; H Dickensheets; R P Donnelly; S Pestka
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

Review 2.  Matrix metalloproteinases and tumor metastasis.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

Review 3.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

4.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.

Authors:  Stephan Brand; Florian Beigel; Torsten Olszak; Kathrin Zitzmann; Sören T Eichhorst; Jan-Michel Otte; Helmut Diepolder; Andreas Marquardt; Wolfgang Jagla; Andreas Popp; Stéphane Leclair; Karin Herrmann; Julia Seiderer; Thomas Ochsenkühn; Burkhard Göke; Christoph J Auernhammer; Julia Dambacher
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-04       Impact factor: 4.052

5.  Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.

Authors:  Weici Zhang; Yongyan Chen; Haiming Wei; Chaogu Zheng; Rui Sun; Jian Zhang; Zhigang Tian
Journal:  Clin Cancer Res       Date:  2008-10-15       Impact factor: 12.531

6.  Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.

Authors:  Lian-Zhen Yu; Hai-Yang Wang; Shu-Ping Yang; Zhi-Ping Yuan; Fang-Yuan Xu; Chao Sun; Rui-Hua Shi
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

7.  Interleukin-22 is frequently expressed in small- and large-cell lung cancer and promotes growth in chemotherapy-resistant cancer cells.

Authors:  Sebastian Kobold; Stefanie Völk; Till Clauditz; Natascha Jennifer Küpper; Sarah Minner; Amanda Tufman; Peter Düwell; Michael Lindner; Ina Koch; Simon Heidegger; Simon Rothenfuer; Max Schnurr; Rudolf Maria Huber; Waldemar Wilczak; Stefan Endres
Journal:  J Thorac Oncol       Date:  2013-08       Impact factor: 15.609

8.  Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10.

Authors:  Diane Lejeune; Laure Dumoutier; Stefan Constantinescu; Wiebe Kruijer; Jan Jacob Schuringa; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

9.  IL-22 increases the innate immunity of tissues.

Authors:  Kerstin Wolk; Stefanie Kunz; Ellen Witte; Markus Friedrich; Khusru Asadullah; Robert Sabat
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

10.  High expression of interleukin-22 and its receptor predicts poor prognosis in pancreatic ductal adenocarcinoma.

Authors:  Zhang Wen; Quan Liao; Jianguo Zhao; Ya Hu; Lei You; Zhaohui Lu; Congwei Jia; Yingxin Wei; Yupei Zhao
Journal:  Ann Surg Oncol       Date:  2013-10-17       Impact factor: 5.344

View more
  19 in total

Review 1.  Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm.

Authors:  Beverly R E A Dixon; Rafat Hossain; Rachna V Patel; Holly M Scott Algood
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 2.  What goes around comes around: novel pharmacological targets in the gut-brain axis.

Authors:  Camila González-Arancibia; Jorge Escobar-Luna; Camila Barrera-Bugueño; Camilo Díaz-Zepeda; María P González-Toro; Loreto Olavarría-Ramírez; Francesca Zanelli-Massai; Martin Gotteland; Javier A Bravo; Marcela Julio-Pieper
Journal:  Therap Adv Gastroenterol       Date:  2016-02-17       Impact factor: 4.409

Review 3.  Biological and pathological activities of interleukin-22.

Authors:  Mirna Perusina Lanfranca; Yanwei Lin; Jingyuan Fang; Weiping Zou; Timothy Frankel
Journal:  J Mol Med (Berl)       Date:  2016-02-29       Impact factor: 4.599

4.  Gut Microbe-Mediated Suppression of Inflammation-Associated Colon Carcinogenesis by Luminal Histamine Production.

Authors:  Chunxu Gao; Bhanu Priya Ganesh; Zhongcheng Shi; Rajesh Rasik Shah; Robert Fultz; Angela Major; Susan Venable; Monica Lugo; Kathleen Hoch; Xiaowei Chen; Anthony Haag; Timothy C Wang; James Versalovic
Journal:  Am J Pathol       Date:  2017-09-13       Impact factor: 4.307

Review 5.  Role of IL-22 in intestinal microenvironment and potential targeted therapy through diet.

Authors:  Peiying Wang; Wing Keung Chan; Jiming Wang; Zhouxin Yang; Youwei Wang
Journal:  Immunol Res       Date:  2022-09-29       Impact factor: 4.505

6.  Interleukin 22 mitigates endothelial glycocalyx shedding after lipopolysaccharide injury.

Authors:  Sharven Taghavi; Sarah Abdullah; Juan Duchesne; Derek Pociask; Jay Kolls; Olan Jackson-Weaver
Journal:  J Trauma Acute Care Surg       Date:  2021-02-01       Impact factor: 3.697

7.  MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression.

Authors:  Jan Bornschein; Tina Seidel; Cosima Langner; Alexander Link; Thomas Wex; Michael Selgrad; Doerthe Jechorek; Frank Meyer; Elizabeth Bird-Lieberman; Michael Vieth; Peter Malfertheiner
Journal:  Diagn Pathol       Date:  2015-12-12       Impact factor: 2.644

8.  IL-17a and IL-22 Induce Expression of Antimicrobials in Gastrointestinal Epithelial Cells and May Contribute to Epithelial Cell Defense against Helicobacter pylori.

Authors:  Beverly R E A Dixon; Jana N Radin; M Blanca Piazuelo; Diana C Contreras; Holly M Scott Algood
Journal:  PLoS One       Date:  2016-02-11       Impact factor: 3.240

Review 9.  The Interleukin-20 Cytokines in Intestinal Diseases.

Authors:  Jan Hendrik Niess; Petr Hruz; Tanay Kaymak
Journal:  Front Immunol       Date:  2018-06-18       Impact factor: 7.561

10.  Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation.

Authors:  Panpan Li; Xin Shi; Yonghui Xu; Binggang Zhong; Yu Lu; Yong Sun
Journal:  Med Sci Monit       Date:  2018-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.